Related Experiment Videos
Glucocorticoids
1Hospital for Special Surgery, Cornell University Medical College, New York, New York.
Abstract:
Despite the continuing debate about the risks and benefits of glucocorticoid, their central role in the therapeutic armamentarium remains undisputed. Studies continue to unravel the complexity of their biologic effects on gene transcription, and careful clinical observation refines their therapeutic use. Although cloaked in controversy, some recent highlights include the possibility that high-dose intravenous methylprednisolone may affect the development of multiple sclerosis, the suggestion that prednisone may have little efficacy in the management of high-risk pregnancy in patients with antiphospholipid antibodies, and several observations that administration of calcium and vitamin D prevents bone loss in patients receiving steroids.
Insights
Glucocorticoids are essential therapeutics despite ongoing risk-benefit debates. Research clarifies their gene effects and clinical applications, including impacts on multiple sclerosis and bone loss prevention with calcium and vitamin D.
Area of Science:
- Endocrinology and Pharmacology
- Immunology
- Reproductive Medicine
Background:
- Glucocorticoids remain crucial in therapy despite risks.
- Ongoing research explores their complex biological mechanisms, particularly gene transcription.
- Clinical practice evolves with careful observation of their effects.
Purpose of the Study:
- To summarize recent advancements in understanding glucocorticoid therapy.
- To highlight key findings regarding their impact on specific diseases and conditions.
- To underscore the importance of continued research into glucocorticoid's multifaceted roles.
Main Methods:
- Review of current scientific literature and clinical observations.
- Analysis of recent studies on glucocorticoid effects.
- Synthesis of data on therapeutic applications and potential adverse effects.
Main Results:
- High-dose intravenous methylprednisolone may influence multiple sclerosis development.
- Prednisone shows limited efficacy in high-risk antiphospholipid antibody pregnancies.
- Calcium and vitamin D supplementation can prevent steroid-induced bone loss.
Conclusions:
- Glucocorticoid therapy requires careful consideration of specific clinical contexts.
- Further research is needed to optimize glucocorticoid use and mitigate risks.
- Preventive strategies like calcium and vitamin D are vital for patients on long-term steroids.